arrow
K

Kaire Innos

national institute for health development
H指数:39
被引数:4.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cancer Patients Mortality From Other Causes: A European Population-Based Study

癌症患者非癌症原因死亡率:一项基于欧洲人群的研究

2026-09-150
OAAI
Corrigendum to “Epithelial head and neck cancer survival in Europe: Geographical variation, time trends and long term survival” Eur J Cancer 229 (October) (2025) 115692

勘误:“Epithelial head and neck cancer survival in Europe: Geographical variation, time trends and long term survival” Eur J Cancer 229 (October) (2025) 115692

2025-11-290
PRE
Global variation in patterns of care and time to initial treatment for breast, cervical, and ovarian cancer from 2015 to 2018 (VENUSCANCER): a secondary analysis of individual records for 275 792 women from 103 population-based cancer registries in 39 countries and territories

2015年至2018年全球范围内乳腺癌、宫颈癌和卵巢癌的护理模式及初始治疗时间差异(VENUSCANCER):一项基于39个国家和地区103个基于人群的癌症登记处275,792名女性个体记录的二次分析

2025-10-220
OAAI
An International Registry Study of Early-Stage NSCLC treatment variations (LUCAEUROPE) in Europe and the USA highlighting variations

欧洲和美国早期NSCLC治疗变异的国际注册研究 (LUCAEUROPE) 突出了变异

2024-09-010
OAAI
Differences in survival and recurrence of colorectal cancer by stage across population-based European registries

基于人群的欧洲登记处按阶段划分的结直肠癌生存和复发的差异

2024-04-055
OA
Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000-2014 (CONCORD-3)
2022-11-1020
OAAI
The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019

可归因于风险因素的全球癌症负担,2010-19: 对全球疾病负担研究2019的系统分析

LANCET
IF88.5
2022-08-01418
OAAI
Rare thyroid malignancies in Europe: Data from the information network on rare cancers in Europe (RARECAREnet)
2020-09-017
OAAI